Biocompatibles UK Ltd. is notifying customers of four additional potential complications that were not implemented in the instruction for use document supplied with the product, DC Bead M1, as agreed to with health Canada on October 18, 2013. These complications were: liver abscess, post embolization syndrome, pancreatitis and tumor rupture.